<scp>Real‐world</scp> effectiveness and safety of insulin glargine 300 <scp>U/ml</scp> in <scp>insulin‐naïve</scp> people with type 2 diabetes in the <scp>Latin America</scp> region: A subgroup analysis of the <scp>ATOS</scp>

Hernando Vargas‐Uricoechea, José Luis Burga Nuñez, Juan Rosas Guzmán, Liliana Silva‐Gomez, Sergio Beltran, María Elena Sañudo‐Maury

Open source

DOI: 10.1111/dom.14868
Published: 2022-10-09
Container: Diabetes, Obesity and Metabolism
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/dom.14868,
  title = {<scp>Real‐world</scp>
                    effectiveness and safety of insulin glargine 300 
                    <scp>U/ml</scp>
                    in
                    <scp>insulin‐naïve</scp>
                    people with type 2 diabetes in the
                    <scp>Latin America</scp>
                    region: A subgroup analysis of the
                    <scp>ATOS</scp>},
  author = {Hernando Vargas‐Uricoechea and José Luis Burga Nuñez and Juan Rosas Guzmán and Liliana Silva‐Gomez and Sergio Beltran and María Elena Sañudo‐Maury},
  year = {2022},
  journal = {Diabetes, Obesity and Metabolism},
  doi = {10.1111/dom.14868},
  url = {https://doi.org/10.1111/dom.14868}
}

RIS

TY  - JOUR
TI  - <scp>Real‐world</scp>
                    effectiveness and safety of insulin glargine 300 
                    <scp>U/ml</scp>
                    in
                    <scp>insulin‐naïve</scp>
                    people with type 2 diabetes in the
                    <scp>Latin America</scp>
                    region: A subgroup analysis of the
                    <scp>ATOS</scp>
AU  - Hernando Vargas‐Uricoechea
AU  - José Luis Burga Nuñez
AU  - Juan Rosas Guzmán
AU  - Liliana Silva‐Gomez
AU  - Sergio Beltran
AU  - María Elena Sañudo‐Maury
PY  - 2022
JO  - Diabetes, Obesity and Metabolism
DO  - 10.1111/dom.14868
UR  - https://doi.org/10.1111/dom.14868
ER  -

APA

Vargas‐Uricoechea, H., Nuñez, J. L. B., Guzmán, J. R., Silva‐Gomez, L., Beltran, S., & Sañudo‐Maury, M. E. (2022). <scp>Real‐world</scp> effectiveness and safety of insulin glargine 300 <scp>U/ml</scp> in <scp>insulin‐naïve</scp> people with type 2 diabetes in the <scp>Latin America</scp> region: A subgroup analysis of the <scp>ATOS</scp>. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.14868

Source records

crossref · retrieved 2026-09-24T23:24:14.200Z